Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BioTime, Inc.
(NY:
BTX
)
4.180
USD
UNCHANGED
Official Closing Price
/ Updated:
6:40 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
133,203
Open
4.180
Bid (Size)
4.100 (200)
Ask (Size)
4.260 (2000)
Prev. Close
4.180
Today's Range
4.120 - 4.350
52wk Range
2.670 - 5.068
Shares Outstanding
55,728,781
Dividend Yield
N/A
Top News
More News
Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support
May 23, 2013
The Israeli Office of the Chief Scientist Approved Cell Cure's Development Budget Totaling NIS 11.5 Million (Over $3 Million USD) with non equity based funding of close to 50%
Read More
from
PR Newswire
BioTime Announces Results of Vote at Special Meeting of Shareholders
May 23, 2013
from
Business Wire News Releases
More News
Read More
BioTime CEO Dr. Michael West to Present at USC Minisymposium: Musculoskeletal Development and Repair
May 20, 2013
from
Business Wire News Releases
BioTime Appoints Franklin Berger to Board of Directors
May 14, 2013
from
Business Wire News Releases
BioTime (BTX) Subsidiary Cell Cure Neurosciences Receives $1.5 Million Grant from Israeli Agency
May 14, 2013
category
Stocks
from
TransWorldNews Current Releases
BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist
May 13, 2013
from
Business Wire News Releases
BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments
May 10, 2013
from
Business Wire News Releases
PDL BioPharma Announces First Quarter 2013 Financial Results
May 09, 2013
from
PR Newswire
BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research
May 07, 2013
from
Business Wire News Releases
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
April 30, 2013
from
PR Newswire
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here